Top Health Stocks
Health care stocks turned most lower today with the NYSE Health Care Sector Index declining 0.6% and shares of health care companies in the S&P 500 falling 0.5% as a group.
In company news, Cytori Therapeutics ( CYTX ) fell Monday after today saying the average therapeutic benefit for patients with systematic sclerosis treated with its ECCS-50 drug candidate declined 50% after 12 months compared with the amount of pain relief they reported after six months.
The 12-month improvements for the Cochin Hand Function Scale and the Raynaud's Condition Score as well as the Scleroderma Health Assessment Questionnaire score all remained consistent with six-month levels, the company said.
CYTX shares were down over 6% at $1.16 each in late trade, up 3 cents off its session low. The stock has traded within a 52-week range of 36 cents to $2.63 a share, already dropping almost 45% over the past year prior to today's decline.
In other sector news,
(+) GBSN, Reports 101 customers at the end of March, a 20% over the end of previous quarter. Also reaffirms forecast of having 170 to 180 U.S. revenue-generating customers by end of 2015 and 40 to 45 more sites in active and scheduled evaluations.
(-) SGNT, Announces launch of 10-gram offering of its vancomycin hydrochloride injection to fight drug-resistant bacteria.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.